Navigation Links
Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market
Date:9/2/2009

CORAL GABLES, Fla., Sept. 2 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) has received approval from The NASDAQ Stock Market to transfer the listing of its common stock from The NASDAQ Global Market(R) to The NASDAQ Capital Market(R). The transfer will be effective at the opening of the market on September 3, 2009. Catalyst will continue to trade under the symbol "CPRX" with no impact on the ability of investors to trade the stock.

The NASDAQ Capital Market(R) is a continuous trading market that operates in the same manner as The NASDAQ Global Market(R). The NASDAQ Capital Market(R) includes the securities of approximately 450 companies. All companies listed on The NASDAQ Capital Market(R) must meet certain financial requirements and adhere to NASDAQ's corporate governance standards.

About Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. For more information about the Company, go to www.catalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including those disclosed in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
4. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
5. CATalyst Summit Declared a Success: Its All About the Cat!
6. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
9. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
10. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
11. CATalyst Council Forms to Address Feline Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... The more hours young ... higher body mass index and bigger waist circumference, a 15-year analysis by the University ... not hold in later years, indicating that young adulthood is an important time to ...
(Date:8/31/2015)... ... 31, 2015 , ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored ... in Mendon, IL. The purpose behind this concert was to raise money for music ... Best Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with a portion of ...
(Date:8/31/2015)... ... 2015 , ... "While working as an anesthesiologist, I observed ... with a lower risk of failure," explained an inventor, from Dearborn Heights, Mich. ... , The Adam Device offers a quick, effective and predictable way to establish ...
(Date:8/31/2015)... Grand Prairie, TX (PRWEB) , ... August 31, ... ... with offices serving communities in and around Grand Prairie, is teaming up with ... senior citizens throughout the area. , Meals on Wheels is the oldest and ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like coming home. ... GreenFields of Geneva. During his first days on the job, he’s run into residents ... them, and I like knowing that they’re living in such a wonderful place,” he ...
Breaking Medicine News(10 mins):Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2
... , , , , ... leaders to push forward commitments to end hunger , -- ... help poor communities adapt , , PITTSBURGH , ... meetings this week, the future of the $20 billion food security initiative first ...
... DUSSELDORF, Germany, September 22 The,Gerresheimer ... with two strategically significant investments in the USA ... opening a new research,and development center for medical ... a,new production center for pharmaceutical plastic packaging in ...
... ... be missing the opportunity to improve their environmental performance because they wrongly assume ... ... sustainability experts Envirowise found that more than half of managers surveyed in the hospitality sector ...
... , WYETH EUROPA, MAIDENHEAD, UK, Sept. 22 ... My Day for RA European event in Barcelona, Spain ... people living with rheumatoid arthritis (RA). , , ... , , RA is a chronic and progressive ...
... , DETROIT, Sept. 21 Rev. Dr. ... and moderator during the Congressional Black Caucus (CBC) Foundation,s 2009 Annual ... September 24, 2009, Rev. Anthony will serve as a panelist during ... Care for All a Reality." Other panelist include: Jacob Hacker, ...
... DC (September 9, 2009) As the economy continues to ... of the crisis on children,s health, education, and rights in ... issue of the journal Global Social Policy , asserts ... rights and break the cycle of poverty, but also safeguard ...
Cached Medicine News:Health News:Summits Alone Won't Feed the Hungry, Aid Agency Says 2Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 2Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 3Health News:London Hospitality Sector Fails To Check-In For Cost Savings 2Health News:London Hospitality Sector Fails To Check-In For Cost Savings 3Health News:Video: Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA) 2Health News:Video: Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA) 3Health News:Video: Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA) 4Health News:Video: Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA) 5Health News:Rev. Dr. Wendell Anthony to Speak at Congressional Black Caucus Foundation Annual Legislative Conference 2Health News:999: The human face of economic crisis 2Health News:999: The human face of economic crisis 3
(Date:8/31/2015)... and STAMFORD, Conn. , ... subsidiary of Eisai Co., Ltd., and Purdue Pharma L.P. ... collaboration agreement for the development and commercialization of Eisai,s ... receptor antagonist entering Phase III clinical development for the ... of the agreement, Eisai and Purdue Pharma will share ...
(Date:8/31/2015)... , Aug. 31, 2015 Bionomics Limited ... and development of innovative therapeutics for the treatment of ... today announced that its BNC101 IND submission has passed ... Bionomics plans to initiate a Phase 1 clinical trial ... with metastatic pancreatic cancer prior to 31 December 2015. ...
(Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ ... Competitors and Opportunities: 2015 - 2020 Analysis and ... Pain is defined as an unpleasant sensory ... tissue damage. At some point, everyone experiences pain. ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
... SCOTTSDALE, Ariz. and WASHINGTON, June 15, 2011 The ... and CAQH CORE ® (Committee on Operating Rules ... collaborate on activities related to harmonizing electronic data interchange ... NCPDP and CAQH CORE began exploring the ...
... Endologix, Inc. (Nasdaq: ELGX ), developer and ... today that it has received U.S. Food and Drug ... AFX™ Endovascular AAA System, for the treatment of abdominal ... Annual Meeting of the Society for Vascular Surgery (SVS), ...
Cached Medicine Technology:NCPDP and CAQH CORE Partner on Harmonizing Operating Rules and Standards Across Healthcare 2NCPDP and CAQH CORE Partner on Harmonizing Operating Rules and Standards Across Healthcare 3Endologix Announces FDA Approval of AFX™ Endovascular AAA System 2Endologix Announces FDA Approval of AFX™ Endovascular AAA System 3
... test combines performance equivalence to 14-day viral culture ... B with a simple, easy-to-use test with results ... all the same procedural steps as our FLU ... decrease costs for unnecessary ancillary testing, improve appropriate ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Shielding's Flex Back Apron is one of our most popular. Similar to the Velcro Adjustable but with elastic back panels for additional support and comfort....
Shielding's Standard Coat Apron with open back allows for freedom of movement, maximum flexibility and increased comfort....
Medicine Products: